Discure Technologies

Discure Technologies Overview

Discure Technologies developed a minimally invasive device to treat and reverse degenerative disc disease, reducing pain and restoring functionality to the patient. The system is designed to eliminate the need for invasive surgery and reduce the use of opioids.

Cumulative Funding Raised Over Time ($)

Latest News

Sep 10, 2024 · www.calcalistech.com

growth-positive

Discure Technologies raises $16 million for degenerative disc disease treatment | CTech

Discure Technologies has successfully completed $16 million in financing to advance its treatment for degenerative disc disease (DDD). The funding includes $11 million from an oversubscribed Series A round and $5 million from a SAFE raise. The Series A round was led by BOLD Capital Partners, Supernova Invest, and Sanara Capital, with participation from U.S. hospital networks, orthopedic surgeons, and medtech investors. The investment will accelerate the companys growth, allowing it to make key hires and fully fund its First-in-Human clinical study in Canada and Italy. Discures novel approach aims to shift the paradigm from symptom management to regenerating the disc.

InvestmentPartnersExpand

Funding

Team Members

5

Employees: 11-50

Web & Social Links

Locations

Medinat HaYehudim Street 85, Herzliya, Israel

Photos & Videos

1 item(s)

Discure Technologies Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info